Stockscreener 앱 받기
5.685
21.48%
-1.555
전일 마감가:
$7.24
열려 있는:
$7.56
하루 거래량:
35,769
Relative Volume:
1.48
시가총액:
$19.63M
수익:
$64.42M
순이익/손실:
$-73.78M
주가수익비율:
-3.3283
EPS:
-1.7081
순현금흐름:
$-60.50M
1주 성능:
-28.49%
1개월 성능:
-36.64%
6개월 성능:
-77.92%
1년 성능:
-93.33%
1일 변동 폭
$5.67
$7.56
1주일 범위
$5.67
$9.10
52주 변동 폭
$5.67
$98.75
Allurion Technologies Inc Stock (ALUR) Company Profile
명칭
Allurion Technologies Inc
전화
508-647-4000
주소
11 HURON DR STE 200, NATICK
ALUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
5.67 | 19.63M | 64.42M | -73.78M | -60.50M | -1.7081 |
|
ABT
Abbott Laboratories
|
112.99 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.13 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
365.97 | 139.65B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.52 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.38 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | 개시 | TD Cowen | Buy |
| 2024-09-06 | 개시 | ROTH MKM | Buy |
| 2024-02-09 | 개시 | Jefferies | Buy |
Allurion Technologies Inc 주식(ALUR)의 최신 뉴스
Allurion reports promising results from obesity treatment trial By Investing.com - Investing.com Canada
Allurion Announces Positive Topline Results From AUDACITY Trial - BioSpace
Allurion Technologies Enhances Financial Agreements and Governance - TipRanks
Allurion announces AUDACITY trial meets one co-primary endpoint, misses other - TipRanks
Allurion reports promising results from obesity treatment trial - Investing.com India
Allurion Technologies expands board, appoints new director - Investing.com
Allurion Technologies expands board, appoints new director By Investing.com - Investing.com Canada
Allurion Technologies Expands Board with New Appointment - MSN
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Allurion Technologies Inc. Withdraws the Device from the French Market - Marketscreener.com
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss - Marketscreener.com
Allurion Technologies, Inc. Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s - Marketscreener.com
Allurion Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Allurion Technologies, Inc. Announces an Expanded Commercial Agreement with Weight Doctors - Marketscreener.com
Certain Restricted stock units of Allurion Technologies Inc. are subject to a Lock-Up Agreement Ending on 27-SEP-2024. - Marketscreener.com
Allurion Technologies Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Allurion Technologies, Inc. Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity - Marketscreener.com
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance - Marketscreener.com
Allurion Receives Continued Listing Standards Notice from NYSE - Marketscreener.com
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 - Marketscreener.com
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery - Marketscreener.com
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss - Marketscreener.com
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program - Marketscreener.com
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion Technologies, Inc. Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference - Marketscreener.com
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity - Marketscreener.com
Allurion Technologies : Proxy Statement Form 8 K - Marketscreener.com
Allurion Technologies Inc. Appoints Brendan Gibbons as Its New Chief Legal Officer and Corporate Secretary - Marketscreener.com
Allurion Technologies, Inc. Announces Publication of New Data Demonstrating Continued Weight Loss at One Year on the Allurion Program - Marketscreener.com
Allurion Launches in the US with Its First AI-Native Compounded GLP-1 Program - Marketscreener.com
Allurion Technologies Inc. Announces the Appointment of Keith Johns to Its Board of Directors - Marketscreener.com
Allurion Technologies Inc. Appoints Ojas A. Buch as Chief Operating Officer - Marketscreener.com
Allurion Technologies Inc. Appoints Adrian Wild as Senior Vice President, International Commercial - Marketscreener.com
Allurion Technologies (NYSE:ALUR) Sees Large Volume IncreaseHere's Why - MarketBeat
Allurion Technologies Announces Reverse Stock SplitOn December 23, 2024, Allurion Technologies, Inc. (NYSE: ALUR) disclosed the approval of a reverse stock split during the 2024 Annual Meeting of Stockholders. The reverse stock split of the Company’s - Defense World
Allurion Technologies : Announces Reverse Stock Split Form 8 K - Marketscreener.com
Financial Review: Alphatec (NASDAQ:ATEC) versus Allurion Technologies (NYSE:ALUR) - Defense World
Allurion Technologies Stock Scheduled to Reverse Split on Friday, January 3rd (NYSE:ALUR) - Defense World
Allurion Technologies to implement reverse stock split - MSN
Allurion Technologies announces reverse stock split By Investing.com - Investing.com Nigeria
Allurion Details Reverse Stock Split - MENAFN.COM
Allurion Technologies Announces 1-for-25 Reverse Stock Split; Shares Fall Pre-Bell - Marketscreener.com
Allurion Technologies announces reverse stock split - Investing.com
Allurion Technologies, Inc. Announces Reverse Stock Split - Business Wire
Allurion Technologies shareholders approve key proposals - Investing.com
Allurion Technologies shareholders approve key proposals By Investing.com - Investing.com UK
Analyze Allurion Technologies Inc (NYSE: ALUR) Before Investing. - Stocks Register
Allurion gains NYSE compliance plan acceptance By Investing.com - Investing.com Canada
Allurion Technologies (NYSE:ALUR) vs. AVITA Medical (NASDAQ:RCEL) Head-To-Head Contrast - Defense World
ALURAllurion Technologies, Inc. Latest Stock News & Market Updates - StockTitan
Allurion Technologies Inc (ALUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
2.52%
자본화:
|
볼륨(24시간):